ZHEJIANG WOLWO BIO-PHARMACEUTICAL CO., LTD.

Andere talen Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Aandelen

300357

CNE100001R58

slotkoers Shenzhen S.E. Andere beurzen 00:00:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
24,05 ^CNY	-0,21%		+1,52%	-17,07%

18/04	Zhejiang Wolwo Bio-Pharmaceutical Co, Ltd. rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
2023	Zhejiang Wolwo Bio-Pharmaceutical Co, Ltd. rapporteert winstresultaten voor de negen maanden eindigend op 30 september 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	18/04
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25-10-23
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24-08-23
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on July 6, 2023	29-06-23
Shanghai Wolwo Stem Cell Technology Co., Ltd. announced that it has received CNY 400 million in funding from Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.	19-06-23
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Approves the Cash Dividend for the Year 2022	19-05-23
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2022	21-04-23
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	20-04-23
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	20-04-23
Shanghai Wolwo Stem Cell Technology Co., Ltd. announced that it expects to receive CNY 400 million in funding from Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. and other investors	20-04-23
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Approves Executive Appointments	29-12-22
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	25-10-22
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	20-07-22
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Implements Final Profit Distribution Plan A shares for 2021, Payable on June 16, 2022	10-06-22
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2021	01-06-22
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2021	27-04-22
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	26-04-22
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	26-10-21
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	15-07-21
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Announces Final Cash Dividend for 2020, Payable on 01 June 2021	26-05-21

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Aandelen

300357

CNE100001R58

Andere talen

Filters